68
Participants
Start Date
April 15, 2016
Primary Completion Date
April 15, 2019
Study Completion Date
December 16, 2019
Vinorelbine
Cycle 1 and 2 50 mg/day, (Monday, Wednesday and Friday)
Cisplatin
Cycle 1 and 2 day 1, 80 mg/m2
Vinorelbine
Cycle 3 and 4 30 mg/day, (Monday, Wednesday and Friday)
Cisplatin
Cycle 3 and 4 day 1, 80 mg/m2
Radiotherapy
concomitant therapy during cycles 3 and 4. Total dose: 66Gy
Hospital Provincial de Castellón, Castellon
H. de Donostia, Donostia / San Sebastian
Hospital de Jaén, Jaén
Hospital Universitario Lucus Augusti, Lugo
H. de la Princesa, Madrid
H.U. Puerta de Hierro, Madrid
Hospital Fundación Jiménez Díaz, Madrid
Hospital Virgen de La Macrena, Seville
Hospital Lluís Alcanyís, Xàtiva
Hospital de Basurto, Bilbao
Hospital Clínico Lozano Blesa, Zaragoza
Hospital General Universitario de Elche, Elche
ICO-Badalona, Badalona
H. Son Espases, Palma de Mallorca
H.G.U. Alicante, Alicante
Hospital de La Santa Creu I Sant Pau, Barcelona
H. Clínico San Carlos, Madrid
H. Son Llàtzer, Palma de Mallorca
Spanish Lung Cancer Group
OTHER